Camosunate Junior (7 - 13 Yrs) Tablets

Camosunate for Children (7–13 Years) – Antimalarial Tablets

Description:

Camosunate is a highly effective antimalarial medication specifically formulated for children aged 7 to 13 years. It contains a fixed-dose combination of Artesunate and Amodiaquine, two World Health Organization (WHO)-recommended active ingredients used for the treatment of uncomplicated Plasmodium falciparum malaria.

Key Features:

• Specifically formulated for children aged 7–13 years

• Combines Artesunate (rapid parasite clearance) and Amodiaquine (sustained antimalarial action)

• Fast-acting and well-tolerated with a high cure rate

• 3-day complete treatment course

• Trusted and widely used in malaria-endemic regions

Indications:

• For the treatment of acute uncomplicated malaria caused by Plasmodium falciparum

• Particularly effective in areas with resistance to older antimalarial drugs

Dosage and Administration:

• Dosage is age-specific and follows a 3-day treatment regimen

• To be taken with food to improve absorption and reduce gastrointestinal side effects

• Must be used under medical supervision

Precautions:

• Not suitable for children under 7 years

• Not recommended for use in individuals with a known allergy to amodiaquine or artesunate

• Monitor for side effects such as nausea, dizziness, or rash

• Complete the full course even if symptoms improve

Storage:

• Store in a cool, dry place below 25°C

• Keep out of reach of children

Note:

This medication is prescription-only. Always consult a healthcare provider for proper diagnosis and treatment of malaria.